Back to Search
Start Over
Cbcsg-10: Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for triple negative breast cancer
- Source :
- Journal of Clinical Oncology. 34:1012-1012
- Publication Year :
- 2016
- Publisher :
- American Society of Clinical Oncology (ASCO), 2016.
-
Abstract
- 1012Background: Standard adjuvant chemotherapy regimens for triple-negative breast cancer (TNBC) contain taxane and anthracycline. We aimed to investigate the efficacy and safety of integrate capec...
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
Taxane
Anthracycline
Cyclophosphamide
business.industry
medicine.disease
Capecitabine
03 medical and health sciences
0302 clinical medicine
Breast cancer
Docetaxel
Internal medicine
medicine
030212 general & internal medicine
business
030217 neurology & neurosurgery
Triple-negative breast cancer
medicine.drug
Epirubicin
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 34
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........7153219522eba48926e8f7d3e08b021d